抗乙肝的现代药物作用机制及临床应用(研究进展)

抗乙肝的现代药物作用机制及临床应用(3)

http://www.100md.com 2007年11月5日《中国医药导报》 2007年第31期

     [11]Cooksley WG, Piratvisuth T, Lee SD, et al.Peginterferon alpha-2a (40kDa): an advance in the treatment of hepatitis B eantigen positivechronic hepatitis B[J]. J Viral Hepat, 2003, 10(4): 298-305.

    [12]Brunetto MR, Oliveri F, Coco B, et al.Outcome of anti-HBe positive chronic hepatitis B in alpha- interferon treated and untreated patients: a long term cohort study[J]. J Hepatol, 2002, 36 (2):263-270.

    [13]Papatheodoridis GV, Manesis E, Hadziyannis SJ. The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis B[J]. J Hepatol, 2001, 34(2): 306-313. ......

上一页第 1 2 3 页

百拇医药网 http://www.100md.com/html/paper/1673-0089/2007/31/12-2.htm

您现在查看是摘要页，全文长 3847 字符。